Differences in Tumour Aggressiveness Based on Molecular Subtype and Race Measured by [
[18F]FDG PET/CT
breast cancer
molecular subtype
race
tumour aggressiveness
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
25
02
2023
revised:
09
06
2023
accepted:
12
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Breast cancer in women of African descent tends to be more aggressive with poorer prognosis. This is irrespective of the molecular subtype. [
Identifiants
pubmed: 37370954
pii: diagnostics13122059
doi: 10.3390/diagnostics13122059
pmc: PMC10297178
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2016 Jan 04;11(1):e0146195
pubmed: 26727114
J Hematol Oncol. 2022 Mar 26;15(1):36
pubmed: 35346315
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):426-35
pubmed: 21057787
Nucl Med Commun. 2000 Aug;21(8):707-14
pubmed: 11039452
JAMA Oncol. 2021 Jul 01;7(7):1016-1023
pubmed: 33983438
Mol Oncol. 2010 Jun;4(3):192-208
pubmed: 20452298
Oncotarget. 2017 Jul 19;8(43):74287-74298
pubmed: 29088785
Int J Womens Health. 2017 Dec 06;9:887-896
pubmed: 29255374
J Cell Commun Signal. 2018 Mar;12(1):119-132
pubmed: 29188479
Breast Cancer Res Treat. 2017 Jun;163(2):321-330
pubmed: 28251385
J Clin Oncol. 2015 Nov 1;33(31):3621-7
pubmed: 26371147
Eur Radiol. 2014 Mar;24(3):610-8
pubmed: 24097303
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Nucl Med Commun. 2019 Oct;40(10):1043-1050
pubmed: 31425343
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1371-7
pubmed: 25947575
Int J Gynecol Cancer. 2010 Jan;20(1):110-5
pubmed: 20130510
Cancer Med. 2018 Apr;7(4):1183-1193
pubmed: 29479835
Biomedicines. 2022 Nov 15;10(11):
pubmed: 36428500
Eur J Public Health. 2017 Feb 1;27(1):173-178
pubmed: 28177503
Cancer Res. 2014 Dec 15;74(24):7583-98
pubmed: 25239452
Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):290-301
pubmed: 23151913
Ann Surg Oncol. 2017 Oct;24(10):2869-2875
pubmed: 28766222
NPJ Breast Cancer. 2018 Mar 20;4:7
pubmed: 29582015
Radiographics. 2016 Mar-Apr;36(2):481-96
pubmed: 26963458
Breast Cancer Res Treat. 2018 Aug;170(3):647-656
pubmed: 29693227
Breast Cancer Res. 2017 Dec 11;19(1):131
pubmed: 29228969
PLoS One. 2019 Dec 11;14(12):e0225959
pubmed: 31826010
JAMA. 2013 Jul 24;310(4):389-97
pubmed: 23917289
Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1317-23
pubmed: 12271413
PLoS One. 2016 Oct 31;11(10):e0165409
pubmed: 27798652
Acta Med Acad. 2020 Apr;49(1):1-8
pubmed: 32738112
Leuk Lymphoma. 2010 Feb;51(2):279-83
pubmed: 20038236
J Clin Oncol. 2010 Apr 1;28(10):1684-91
pubmed: 20194857
Nucl Med Commun. 2020 Aug;41(8):824-829
pubmed: 32516244
World J Clin Oncol. 2014 Aug 10;5(3):412-24
pubmed: 25114856
Cancer. 2008 Mar 1;112(5):995-1000
pubmed: 18098228
Lancet Oncol. 2001 Mar;2(3):133-40
pubmed: 11902563
Breast J. 2018 Jul;24(4):615-619
pubmed: 29265644
J Breast Cancer. 2017 Sep;20(3):297-303
pubmed: 28970856
Clin Transl Oncol. 2012 Jun;14(6):481-5
pubmed: 22634538
J Natl Cancer Inst. 2012 Jul 18;104(14):1094-101
pubmed: 22773826
PLoS One. 2018 Apr 26;13(4):e0196134
pubmed: 29698415
Medicine (Baltimore). 2022 Sep 30;101(39):e30798
pubmed: 36181127
Sci Rep. 2017 Mar 27;7:45411
pubmed: 28345619